Ramsay Kay A, McTavish Sharla M, Wardell Samuel J T, Lamont Iain L
Department of Biochemistry, University of Otago, Dunedin, New Zealand.
Front Microbiol. 2021 Dec 20;12:789550. doi: 10.3389/fmicb.2021.789550. eCollection 2021.
chronically infects in the lungs of people with cystic fibrosis and other forms of lung disease. Infections are treated with antibiotics, but over time, the bacteria acquire mutations that reduce their antibiotic susceptibility. The effects of inhibitory amounts of antibiotics in selecting for antibiotic-resistant mutants have been well studied. However, the concentrations of antibiotics that reach infecting bacteria can be sub-inhibitory and but may nonetheless promote emergence of antibiotic-resistant bacteria. Therefore, the aim of this research was to investigate the effects of sub-inhibitory concentrations of antibiotics on the antibiotic susceptibility of . Two reference strains, PAO1 and PA14, and six isolates from individuals with cystic fibrosis were studied. The bacteria were passaged in the presence of antibiotics (ceftazidime, ciprofloxacin, meropenem or tobramycin) at sub-inhibitory amounts. Fifteen populations of bacteria (up to five per strain) were exposed to each of the four antibiotics. Antibiotic susceptibility was determined following 10 passages on agar supplemented with antibiotic and compared with susceptibility prior to antibiotic exposure. Antibiotic exposure resulted in susceptibility being significantly (>2-fold) reduced for 13 of the 60 populations. Seven samples had reduced susceptibility to ciprofloxacin, three to tobramycin, two to ceftazidime and one to meropenem. Whole-genome sequencing revealed the mutations arising following antibiotic exposure. Mutants with reduced antibiotic susceptibility had mutations in genes known to affect antibiotic resistance, including regulators of efflux pumps (, , and ) and the gene that is associated with aminoglycoside resistance. Genes not previously associated with resistance, including , and and two genes with no known function, were also mutated in some isolates with reduced antibiotic susceptibility. Our results show that exposure to sub-inhibitory amounts of antibiotics can select for mutations that reduce the susceptibility of to antibiotics and that the profile of mutations is different from that arising during selection with inhibitory antibiotic concentrations. It is likely that exposure to sub-inhibitory amounts of antibiotics during infection contributes to becoming antibiotic-resistant.
长期感染患有囊性纤维化和其他形式肺部疾病患者的肺部。感染用抗生素治疗,但随着时间的推移,细菌会发生突变,降低其对抗生素的敏感性。抗生素抑制量在选择抗生素抗性突变体方面的作用已得到充分研究。然而,到达感染细菌的抗生素浓度可能是亚抑制性的,但仍可能促进抗生素抗性细菌的出现。因此,本研究的目的是调查亚抑制浓度的抗生素对[细菌名称未给出]抗生素敏感性的影响。研究了两个参考菌株PAO1和PA14,以及来自囊性纤维化患者的六个分离株。细菌在亚抑制量的抗生素(头孢他啶、环丙沙星、美罗培南或妥布霉素)存在下传代。15个细菌群体(每个菌株最多5个)暴露于四种抗生素中的每一种。在补充有抗生素的琼脂上传代10次后测定抗生素敏感性,并与抗生素暴露前的敏感性进行比较。抗生素暴露导致60个群体中的13个群体的敏感性显著(>2倍)降低。7个样本对环丙沙星的敏感性降低,3个对妥布霉素的敏感性降低,2个对头孢他啶的敏感性降低,1个对美罗培南的敏感性降低。全基因组测序揭示了抗生素暴露后出现的突变。抗生素敏感性降低的突变体在已知影响抗生素抗性的基因中发生了突变,包括外排泵的调节因子([具体基因名称未给出])和与氨基糖苷抗性相关的[具体基因名称未给出]基因。一些抗生素敏感性降低的分离株中,以前与抗性无关的基因,包括[具体基因名称未给出]、[具体基因名称未给出]和[具体基因名称未给出]以及两个功能未知的基因也发生了突变。我们的结果表明,暴露于亚抑制量的抗生素可以选择降低[细菌名称未给出]对抗生素敏感性的突变,并且突变谱与在抑制性抗生素浓度选择过程中出现的不同。感染期间暴露于亚抑制量的抗生素可能导致[细菌名称未给出]产生抗生素抗性。